Business Standard

Coronavirus outbreak: Pharma market grows 9% in March due to panic buying

Cardio-diabetic and respiratory segments clock robust growth

Pharma, medicine, drugs, Pharmaceuticals
Premium

However, some therapy areas that are driven primarily by fresh prescriptions, like dermatology, gynaecology, vaccines, have seen a dip in sales.

Sohini Das Mumbai
Despite a nationwide lockdown that disrupted the distribution of drugs across the country and fresh prescription generation, pharmaceutical sales in March registered an 8.9 per cent growth. This was primarily on account of panic buying of medicines in the chronic categories.
 
Cardiac therapy drugs, for example, saw a 19.8 per cent growth compared to 11 per cent in February, anti-diabetic therapy, too, saw a strong growth of 18.2 per cent in March, compared to 11 per cent the previous month. With the coronavirus disease (Covid-19) outbreak, sales of respiratory medicines too saw a sharp spike at around 23 per cent.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in